BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Centene Receives Top Score in the Disability Equality Index

  Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives, announced it has received a top score of 100% in the 2023 Disability Equality Index®, a comprehensive benchmarking tool that measures disability inclusion in the workplace.

  July 11, 2023

   · 

  3 min read
• Business

  Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors

  Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, announced the appointment of Habib Dable as a member of Aerovate’s Board of Directors.

  July 11, 2023

   · 

  4 min read
• Biotech Beach

  Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 11, 2023

  Travere Therapeutics, Inc. announced that on July 10, 2023, the Compensation Committee of its Board of Directors granted inducement equity grants to three new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 13,750 shares of its common stock.

  July 11, 2023

   · 

  1 min read